✦ LIBER ✦

HPV Vaccines: Preclinical Development

✍ Scribed by Lutz Gissmann

Book ID: 113467324
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 98 KB
Volume: 40
Category: Article
ISSN: 0188-4409
DOI: 10.1016/j.arcmed.2009.07.002

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Development of therapeutic HPV vaccines

✍ Cornelia L Trimble; Ian H Frazer 📂 Article 📅 2009 🏛 The Lancet 🌐 English ⚖ 121 KB

HPV vaccines

✍ Margaret Stanley 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 186 KB

Preclinical and Clinical Development of

Preclinical and Clinical Development of New Vaccines

✍ S. Plotkin; F. André; J. Poolman; J. Robbins; D. Salisbury; D. Wood 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 42 KB

Chapter 11: HPV vaccines: Commercial Res

Chapter 11: HPV vaccines: Commercial Research & Development

✍ Stephen Inglis; Alan Shaw; Scott Koenig 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 112 KB

Preclinical development of highly effect

Preclinical development of highly effective and safe DNA vaccines directed against HPV 16 E6 and E7

✍ Koen Oosterhuis; Peter Öhlschläger; Joost H. van den Berg; Mireille Toebes; Raqu 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 French ⚖ 549 KB

To allow vaccination irrespective of HLA type, DNA vaccines encoding full-length antigens are required. However, here, we demonstrate that the immunogenicity of DNA vaccines encoding the full-length human papillomavirus (HPV) type 16 E7 and E6 proteins is highly reduced compared to vaccines encoding

Financing HPV vaccination in developing

Financing HPV vaccination in developing countries

✍ The Lancet 📂 Article 📅 2011 🏛 The Lancet 🌐 English ⚖ 95 KB